Evotec OAI and Panacos Enter into Medicinal Chemistry Agreement to Design and Optimise Novel Anti-HIV Compounds
29-Mar-2004 -
Hamburg, Oxfordshire, Gaithersburg. Evotec OAI AG and Panacos Pharmaceuticals,
Inc., a biotechnology company developing novel antiviral drugs
for the treatment of Human Immunodeficiency Virus (HIV) infection and
other major viral diseases, announced that they have entered into a
medicinal ...
biotechnology
chemistry
clinical trials
+7